Adelaide biotech BiomeBank lands $15 million Blackmores investment
Adelaide-based BiomeBank has secured major backing from Blackmores, strengthening its commercial pathway and raising the profile of local biotech.
Adelaide-based BiomeBank has secured a $15 million investment from Blackmores, giving the local biotechnology company fresh backing to expand its microbiome platform.
The InDaily report describes the deal as major support for the clinical-stage company, with Blackmores deepening its exposure to microbiome and gut-health innovation through a South Australian business.
This is exactly the sort of local business story worth paying attention to. It combines South Australian science, external capital and the prospect of commercial scaling in a health sector that is both globally competitive and research-intensive.
The local significance is wider than one funding round. Deals like this help shape Adelaide’s reputation as a place where specialised health and biotech businesses can attract serious partners, not just early-stage attention.
Resilience Lens:
For South Australia, this matters because it shows external capital is still willing to back specialised South Australian science where the commercial thesis is strong. It also strengthens Adelaide’s positioning as a serious health and biotech city, rather than only a research feeder into larger interstate or offshore markets.
Sources:
About C4R™ - CENTRE FOR RESILIENCE :
C4R™- CENTRE FOR RESILIENCE provides curated, source-based analysis and reporting, combining verified news with strategic insight and resilience-focused interpretation. For in depth analysis of topics like these reach out to C4R™.
C4R™ - CENTRE FOR RESILIENCE is an independent, Australian-based Think Tank initiative advancing economic, social, infrastructure and leadership resilience through research, measurement and practical programs with business, government and community partners. Learn more at https://www.c4resilience.com/.
Media enquiries: via the C4R Contact page.